StopDown
PHPharmEasy logo
News · 5 October 2026PharmEasyOnline pharmacy parentpharmeasy.in ↗

PharmEasy parent clears debt, weighs IPO return

By ·

NewsHealthcare & Life SciencesMumbaiFounded 2019
  • API Holdings owns the PharmEasy online pharmacy and the Ascent and Aknamed businesses, and is backed by TPG and other global funds
  • It paid off its Rs 1,050 crore term debt using money from selling part of Thyrocare plus its own cash, keeping a 51% stake in Thyrocare
  • Its chief executive says profit outside Thyrocare is targeted by September 2027, and a listing or a Thyrocare merger stays possible later

What happened

  • API Holdings repaid its term debt of Rs 1,050 crore.
  • Money came from a part sale of Thyrocare and internal cash.
  • It still holds a 51.02% controlling stake in Thyrocare.
  • Group level is already profitable including Thyrocare.
  • Profit excluding Thyrocare is targeted by September 2027.

Why it matters

  • A debt-free balance sheet makes a future IPO easier.
  • Management says profit comes before any listing decision.
  • A merger with Thyrocare is another option.

The business

  • API Holdings is the parent of the PharmEasy online pharmacy.
  • It also runs Ascent and Aknamed.
  • These units are earning positive operating profit before head-office costs.

Who put in money

In numbers

Rs 1,050 croreTerm debt repaid · 2026

What happens next

  • Profit excluding Thyrocare by September 2027

Read it as a card in the app

More on PharmEasy

Everything on PharmEasy →

Same day

All startup news on 5 October 2026 →

Is this PharmEasy? Get your “Featured on StopDown” badge →